|
|
Industry Satellite Symposia
| Saturday |
Sunday|
Monday |
Tuesday |
SATURDAY, 9 JUNE
16.30 - 18.00 Room C
Industry Sponsored Symposium: Allergan
ISY01 – Focus on macula edema
Moderator: Gisele Soubrane, France
Moderator: J. Haller
Intro and welcome
Gisele Soubrane, France; J. Haller
Diabetic ME – what is it
J. Haller
High Resolution Imaging – a New In Vivo Technology for Following
Individual Cells in Retinal Disease
Wolfgang Drexler, United Kingdom
Why use an anti-inflammatory approach in ME?
Albert Augustin, Germany
Why use Combination therapy in ME?
Francesco Bandello, Italy
Safe delivery of intravitreal drugs – clinical implications
B. Kupperman
Panel debate - Patient cases discussion
16.30 - 18.00 Room D
Industry Sponsored Symposium: Alcon
ISY02 – Paradigm revolution in ophthalmology
Moderator: Norbert Pfeiffer, Germany
Role of contribution of elements in DuoTravTM solution
Howard Barnebey, United States
Importance of preventing CME in cataract surgery
Joseph Colin, France
Circadian IOP – lowering efficiacy of Travoprost compared with
Latonoprost
Julián Carcía Feijoo, Spain
Ocular Allergic and Particulate Irritation
Bob Lanier, United States
DuoTravTM clinical review
Norbert Pfeiffer, Germany
Microcoaxial Torsional Phaco – a perfect marriage
Khiun F. Tjia, The Netherlands
SUNDAY, 10 JUNE
12.00 - 13.15 Room D
Industry Sponsored Symposium: Novartis
ISY03 – Challenging current practice in AMD
Moderator: Don Curran, United Kingdom
Introduction
Don Curran, United Kingdom
Vision improvement as the new standard of care in neovascular AMD
Ursula Schmidt-Erfurth, Austria
Combination therapy – from theory to practice as a rational
treatment option
Paolo Lanzetta
Managing your clinic in the anti-VEGF era: A view on clinic
procedures
Florian Sutter
Panel discussion
Closing remarks
Ursula Schmidt-Erfurth, Austria
16.30 - 18.00 Room B
Industry Sponsored Symposium: AMO
ISY04 – Redefining refractive surgery: optimizing visual acuity and
quality outcomes for corneal and
cataract patients
Moderator: Michael Knorz, Germany
What ISN’T a refractive procedure today? Providing complete
refractive choice
Michael Knorz, Germany
Iris-registered wavefont-guided versus phoroptor-guided PRK: how do
they compare?
Julian Stevens, United Kingdom
Refining refractive outcomes through combining femtosecond and
wavefront-guided
Michael Knorz, Germany
Pupil centroid shift: is it only important for wavefront-guided
ablations?
Osama Ibrahim, Egypt
Update on the global real-world experience with presbyopia ablations
Osman Oram, Turkey
Panel Discussion
Spectacle independence with multifocal IOLs
H. Burkhard Dick, Germany
Visual performance with multifocal lenses
Werner Huetz, Germany
Creating a premium surgical environment for success with premium
IOLs
I. Howard Fine, United States
Refractive enhancements for pseudophakic patients
John Vukich, United States
Panel Discussion
Conclude
16.30 - 18.00 Room C
Industry Sponsored Symposium: Pfizer
ISY05 – Farsighted management for neovascular AMD: seeing the
broader horizon of risk
Moderator: TBA
Understanding the challenge of neovascular AMD
Speaker TBA
Improving diagnosis in Wet AMD: When is CNV not CNV, but RAP?
Speaker TBA
The rationale for selective inhibition: recognizing the intraocular
function of VEGF
David Shima, United Kingdom
Positive outcomes in Wet AMD through selective inhibition of VEGF
Speaker TBA
The rationale for selective inhibition: recognizing the systemic
function of VEGF
Frank Ruschitzka, Switzerland
MONDAY, JUNE 11
16.30 - 18.00 Room D
Industry Sponsored Symposium: Pfizer
ISY06 – The evolution of glaucoma management: evaluating an
exceptional decade
Moderator: Norbert Pfeiffer, Germany
Welcome and introduction
Norbert Pfeiffer, Germany
Pioneering glaucoma therapy: the introduction of the first
prostaglandin
Clive Migdal, United Kingdom
Evidence-based glaucoma management: the decade of the landmark trial
Anders Heijl, Sweden
Enhancing clinical practice through advanced diagnostics
Hans Lemij, The Netherlands
A vision for the future: building on ten years of achievement
Norbert Pfeiffer, Germany
16.30 - 18.00 Room G
Sponsored by Allergan
ISY07 – Best of Posters
Moderator: Michael Foerster, Germany
The best posters will be selected for presentation at the Best of
Posters session. Authors of the selected
posters have been notified in advance and will be invited to make a
short oral presentation in the Best of
Posters session.
A wine reception will be held after the session in the foyer outside
the session room.
TUESDAY, JUNE 12
08.30 - 10.00 Room I
Industry Sponsored Symposium: Santen
ISY08 – Antibiotics for the prophylaxis of post-operative
endophthalmitis
Moderator: David Seal, United Kingdom
Endophthalmitis. Incidence and risk factors
Uwe Pleyer, Germany
The ESCRS endophthalmitis prevention study. Results and the Salzburg
experience
Stefan Egger, Austria
Sensitivity of bacterial pathogens isolated from elderly patients
with community-acquired eye infections
Michael Kresken, Germany
The case for continued use of topical levofloxacin 0.5% as
prophylaxis in cataract surgery
David Seal, United Kingdom
|
|
